Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • May 19, 2018
    Five Senators Ask Drug Companies to Voluntarily Disclose Prices in DTC Ads
  • May 19, 2018
    Conn. Legislature Approves Bill Requiring Drug Reporting
  • May 18, 2018
    N.J. Sales Rep. Licensing Bill Introduced
  • May 17, 2018
    Justice, Five States Join Lawsuit Over Insys’ Subsys Promotion
  • May 16, 2018
    Six More States Sue Opioid Makers Over Marketing
  • May 16, 2018
    Pa. Appeals Court Upholds Pre-emption in ‘Off-label’ Marketing Case
  • May 16, 2018
    Study of Broadcast DTC Ads Finds Less Educational Value Than in 2004 Examination
  • May 15, 2018
    Researchers Find Association Between Opioid Payments and Subsequent Prescribing
  • May 11, 2018
    Appeals Court Upholds Dismissal of Fax Case
  • May 10, 2018
    California Cases Allege Gilead Misrepresented Drug Toxicity
  • More

Good Clinical Practice

  • Sep 11, 2018
    ACRP Gains First Supporter for Partners in Workforce Advancement Initiative
  • Sep 2, 2018
    Study Finds Clinical Trials Are Taking More Than a Year To Publish
  • Aug 29, 2018
    FDA Starts Pilot Program for Meetings on Using Complex Innovative Trial Designs
  • Aug 28, 2018
    Public Citizen Asks OHRP To End Enrollment in NHLBI Trial and To Launch an Investigation
  • Aug 26, 2018
    FDA Recommends Spare Use of Placebos in Hematologic Malignancy and Oncologic Trials
  • Aug 23, 2018
    FDA Report Offers Four Strategies for Better Trial Enrollment
  • Aug 20, 2018
    Pa. Legislation Planned To Expand Right to Try To Stem Cell Treatments
  • Aug 17, 2018
    Broader Trial Enrollment Could Blunt Demand for Right to Try Access
  • Aug 17, 2018
    ORI Looks for Workshop Partners
  • Aug 17, 2018
    NIH, FDA Look To Streamline HGT Trial Oversight
  • More

U.S. Food Labeling

  • Feb 6,2014
    Cargill Begins Rolling Out Disclosure Labels For Ground Beef Made With ‘Pink Slime’
  • Jan 29,2014
    Proposals To Change Nutrition Labels, RACC Under OMB Review
  • Jan 28,2014
    Warning Letter Hits Medical Food Company Over Labeling, Site Claims
  • Jan 23,2014
    Open Letter Pushes Obama To Act on GMO Labeling
  • Jan 23,2014
    New Hampshire’s GMO Bill Falls Short in Key House Vote
  • Jan 16,2014
    Maine Governor Recognizes GMO Law in Signing Ceremony, Measure Won’t Be Finalized Until Fall
  • Jan 14,2014
    FDA Guidance Draws Distinctions Between Beverages, Supplements In Effort To Rein in Energy Drinks
  • Jan 9,2014
    FDA Won’t Rule on Use of ‘Natural’ Labeling For Products Made From Modified Ingredients
  • Jan 3,2014
    Cheerios Goes GMO Free, Label Trumpets Change
  • Dec 31,2013
    CFSAN Warning Letter Targets Supplement Manufacturer Over Drug-like Claims on Sites
  • More

FDA Regulation & Enforcement

  • Jul 23, 2021
    State AGs Reach Settlement with J&J, Distributors
  • Jul 22, 2021
    FDA Releases Preview of Planned Upcoming Labeling Guidances
  • Jul 21, 2021
    St. Jude Medical To Pay $27 Million To Settle False Claims Allegations Linked to Faulty Heart Devices
  • Jul 16, 2021
    OPDP Issues Second Untitled Letter of 2021
  • Jul 15, 2021
    OIG: Plan To Provide Transportation, Lodging, Meals for Drug Treatment Will Not Lead to Fraud Sanctions
  • Jul 15, 2021
    Alere To Pay $38.75 Million To Resolve Allegations That It Knowingly Sold Defective Blood Monitors
  • Jul 14, 2021
    Physician Sentenced to More than 17 Years in Prison for Kickback, Controlled Substances Violations
  • Jul 11, 2021
    Two Bills Introduced in Senate Call for Price Disclosures in Direct-to-Consumer Ads
  • Jul 8, 2021
    Avanos Medical $22 Million Settlement Resolves Charge of Fraudulently Misbranding Surgical Gowns
  • Jul 8, 2021
    In 2-1 Decision, D.C. Circuit Rules That FDA May Not Ban a Medical Device for a Particular Purpose
  • More

Medical Devices

  • Sep 19, 2016
    Physician’s Felony Adulteration Conviction for Reusing Single-Use Devices Upheld on Appeal
  • Sep 14, 2016
    Seller of Counterfeit Contact Lenses Imported from Asia Pleads Guilty to Conspiracy Charge
  • Sep 12, 2016
    MDSAP Invites Device Makers To Participate in Single Audit Program as Implementation Nears
  • Sep 12, 2016
    FDA Issues Draft Guidance Updating Guidelines for 510(k) Third Party Review Program
  • Sep 7, 2016
    As UDI Compliance Date for Class II Devices Looms, Some Products Receive Extensions
  • Aug 30, 2016
    FDA Expands Enforcement Discretion Period for Medical Devices Bearing Some Non-UDI Coding
  • Aug 25, 2016
    Final Guidance Encourages Inclusion of Patient Preference Information in Device Submissions
  • Aug 18, 2016
    Kentucky Files Suit Against J&J, Ethicon Over Deceptive Marketing of Surgical Mesh
  • Aug 16, 2016
    FDA: New Pre-Request for Designation Process for Combination Products Is Available
  • Aug 10, 2016
    Biomet Says Additional Liabilities ‘Probable’ Due to Alleged Marketing Practices in Brazil, Mexico
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.